In our current study of MM, we found that SMAD1 expression is reduced after NF-κB1 knockdown, and vice versa, suggesting that SMAD1 may contribute to MM progression by activation of NF-κB1. The gene discussed is NFKB1; the disease is Miyoshi myopathy.